-
Functional connectivity alterations in individuals with gaming disorder assessed by functional magnetic resonance imaging: a systematic review Journal of Addictive Diseases (IF 2.065) Pub Date : 2024-03-11 Apolinario de Oliveira Botelho, Francieli Bernardo Ribeiro, Jéssica Soares Machado, Daiane Cristini Barbosa de Souza
Neuroimaging has continually advanced, playing a crucial role in the accurate diagnosis of various brain pathologies and disorders. This integrative review aimed to identify the main changes in bra...
-
President’s message Journal of Addictive Diseases (IF 2.065) Pub Date : 2024-03-04 Jon Lepley
Published in Journal of Addictive Diseases (Ahead of Print, 2024)
-
10-year retention of a comprehensive treatment model of buprenorphine for opioid use disorder Journal of Addictive Diseases (IF 2.065) Pub Date : 2024-02-24 Wanhong Zheng, Megan Cavrak, Hannah Bowles, Yongjia Deng, Sijin Wen, Si Gao, Laura Lander, James Berry, Erin L. Winstanley
There has been extensive research demonstrating the effectiveness of medications for opioid use disorder (MOUD) but limited investigation into its long-term retention rate.Assess the long-term trea...
-
Trends in maternal opioid use: Statewide differences by sociodemographic characteristics in Florida from 2000 to 2019 Journal of Addictive Diseases (IF 2.065) Pub Date : 2024-02-18 Amanda L. Elmore, Nansi S. Boghossian, Alexander C. McLain, Suzanne McDermott, Jason L. Salemi
Maternal opioid use (MOU) remains a public health concern. Studies have demonstrated significant increases in MOU, but estimates using ICD-10-CM or stratified by sociodemographic variables are limi...
-
Short-term effects of semaglutide among patients with obesity with and without food addiction: an observational study Journal of Addictive Diseases (IF 2.065) Pub Date : 2024-02-18 Joana Nicolau, María Isabel Tamayo, Pilar Sanchís, Antelm Pujol, Guadalupe Pérez-Bec, Guido Sfondrini, Lluís Masmiquel
Food addiction (FA) is highly prevalent among people with obesity (PwO) and may constitute a key factor in weight loss failure or weight regain. GLP-1 analogues have been shown to act on the mesoli...
-
Prevalence and drug use correlates of inadvertent fentanyl exposure among individuals misusing drugs in seven U.S. states Journal of Addictive Diseases (IF 2.065) Pub Date : 2024-02-14 S. Magura, M. J. Lee-Easton, R. Abu-Obaid, P. Reed, B. Allgaier, E. Fish, A. L. Maletta, P. Amaratunga, B. Lorenz-Lemberg, M. Levitas, E. D. Achtyes
Fentanyl has emerged as the leading cause of fatal drug overdoses in the U.S. Individuals misusing drugs may not always be aware of exposure to fentanyl.To determine the prevalence of fentanyl use ...
-
Buprenorphine: two adolescent case reports of bridging the transmucosal form to the extended-release subcutaneous injectable form Journal of Addictive Diseases (IF 2.065) Pub Date : 2024-01-25 Vivek Velagapudi, Luke Schuster, Roopa Sethi
According to the Centers for Disease Control and Prevention (CDC), 100,306 drug overdose deaths occurred in the US during a 12-month period ending in April 2021. Opioids were involved in 75% of the...
-
President’s message Journal of Addictive Diseases (IF 2.065) Pub Date : 2024-01-11 Jon Lepley
Published in Journal of Addictive Diseases (Vol. 42, No. 1, 2024)
-
Mandating reimbursement for non-FDA-regulated cannabis is bad public policy Journal of Addictive Diseases (IF 2.065) Pub Date : 2024-01-11 Stuart Gitlow, Gregory Bunt, Frank Dowling
An influential cannabis lobby and its allies are engaged in an aggressive initiative to mandate health and worker’s compensation insurance coverage for non-standardized, non-FDA-regulated cannabis ...
-
Suicidal ideations and self-dehumanization in recently detoxified patients with severe alcohol use disorder: an experimental exploration through joint explicit-implicit measures Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-12-19 Sullivan Fontesse, Tina Chevallereau, Florence Stinglhamber, Stéphanie Demoulin, Anna Fiorito, Armand Chatard, Nemat Jaafari, Pierre Maurage
Metadehumanization (the feeling of being considered as less than human by others) is a pervasive phenomenon in psychiatric states, notably promoting self-dehumanization and suicide antecedents. How...
-
A social media analysis of kratom use to discontinue stimulants Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-12-17 Jill R. Settle, Alexandria Smith, Paula Rausch
While FDA-approved treatments exist for opioid use disorder, none are available for stimulant use disorder. Kratom (Mitragyna speciosa), an unregulated plant-derived substance with known opioid- an...
-
Severe tianeptine withdrawal symptoms managed with medications for opioid use disorder: a case report Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-12-14 Varun Y. Rawal, Matthew Gallardo, Katelyn Henderson, Orman Trent Hall, Nicholas Klisovic, Eleonora Sikic-Klisovic
Tianeptine is a tricyclic antidepressant (TCA) without FDA-approval that acts on dopamine and norepinephrine. It has opioid agonist activity and is increasingly being used for recreational purposes...
-
Psychiatric and obstetric characteristics of pregnant crack users admitted to a referral center in Southern Brazil Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-12-04 Jéssica Veras Eloy Santos, Nadine Anita Fonseca da Silva, Laisa Marcolela Andreoli Sartes, Jaqueline Bohrer Schuch, Felix Henrique Paim Kessler, Mauro Barbosa Terra
Psychoactive substance use among pregnant women has reached alarmingly high rates. Our aim was to characterize the psychiatric and clinical profiles of pregnant crack users in Brazil.This was a cro...
-
Cardiovascular health in kratom users; a narrative review Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-11-20 Fatemeh Chichagi, Reyhaneh Alikhani, Asghar Beigi Harchegani
Kratom, also known as Mitragyna speciosa, is a plant that originates in Southeast Asia and possesses unique pharmacological characteristics. It is commonly consumed in the form of tea made by boili...
-
Characterizing safer drinking strategies among hospitalized adults with severe alcohol use disorder; a cross-sectional secondary analysis Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-11-09 Jennifer Lyden, Ryan Loh, Hannan Braun, Dale Terasaki
Safer drinking strategies (SDS) reduce alcohol-related harms in outpatient settings. Little is known about SDS among hospitalized patients.Evaluate SDS among hospitalized patients with alcohol use ...
-
Levels of vitamin D and a bone resorption marker in the sera of young women with alcohol use disorder. Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-11-11 Kayo Masuko,Chie Iwahara,Shigemi Kamiya,Seiji Sakate,Yuki Mizukami
BACKGROUND Excessive alcohol drinking negatively affects bone metabolism and leads to a risk of decreased bone mass, which is a major component of the pathogenesis of osteoporosis. However, the potential influence of alcohol on bones has not been fully recognized, particularly among the young to middle-aged generation. OBJECTIVES This study aimed to investigate the status of serum markers related to
-
Kratom use and mental health: A systematic literature review and case example. Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-11-09 Anil K Bachu,Prakamya Singal,Brittany Griffin,Lauren Harbaugh,Sakshi Prasad,Lakshit Jain,Syed Mohiuddin,Bhavani Nagendra Papudesi,Tarika Nagi,Nagy A Youssef,Amit Chopra,Saeed Ahmed
OBJECTIVE This review aims to synthesize and critically evaluate the existing literature on kratom use and its possible association with induction of psychotic and manic symptoms, in order to identify potential areas for future research that would improve our understanding of the risks of kratom consumption. METHODS An electronic search was performed using five major databases: including PubMed, Scopus
-
Treatment of poppy seed tea misuse with buprenorphine in a telehealth practice: a case series Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-11-01 Amelia Burgess, Julie Craig, Emily N. Miller, Brian Clear, Scott G. Weiner
Poppy seed tea (PST) is a legally obtainable source of opiates made from the seeds of the opium poppy. Our large telehealth opioid use disorder (OUD) provider group has treated several patients wit...
-
Association of depression and smoking cessation: outcomes of an 18-year retrospective cohort study Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-10-18 Haruyuki Kawai, Jun Kondo, Kenji Kuwaki, Maiko Hayashibara, Aguri Nakamura, Naoko Sato, Mari Fujii, Mihoko Kato, Tomomi Ohara, Naomi Wakimoto, Mika Honiden, Shinji Takata
Depression is frequently associated with unsuccessful smoking cessation.In this study, we investigated the impact of depression history on smoking cessation success in a clinical setting.This retro...
-
Barriers to seeking treatment for alcohol use disorders among males in a tertiary care center in South India – a cross-sectional study Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-10-13 Mathew Veena, Johnson-Pradeep Ruben, Nisha Chacko Kunjumon, Harshad Devarbhavi
There are limited studies on barriers to seeking treatment for Alcohol Use Disorders (AUD) among males in tertiary care centers in India and abroad. Identification of these factors can aid in addre...
-
Emotion dysregulation and affective temperaments in opioid use disorder: a 1-year follow-up study Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-10-10 Gamze Zengin İspir, Mustafa Danışman, Kübra Sezer Katar, Rıza Gökçer Tulacı, Kadir Özdel
Opioid use disorder (OUD) remains a significant public health challenge with high recurrence rates and varied long-term outcomes. Affective temperament and emotion regulation have been identified a...
-
Factors related to opioid misuse among patients undergoing elective surgery in Poland. Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-09-30 Jakub Klimkiewicz,Maria Wysocka,Martyna Hordowicz,Jerzy Jarosz,Mateusz Gutowski,Kamil Paryż,Anna Kieszkowska-Grudny,Anna Klimkiewicz
In many countries, the consumption of illicit opioids is rising, becoming a major public health issue called the "opioid crisis". Many reasons contribute to this phenomenon. One of them is opioid misuse, defined as the use of legally prescribed opioids for a purpose different than pain treatment. This matter has not been well studied in Poland, where the opioid crisis has not been identified so far
-
Need to rethink tDCS protocols for the treatment of alcohol use disorder: Insights from a randomized sham-controlled clinical trial among detoxified inpatients Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-09-14 Prabhoo Dayal, Gauri S. Kaloiya, Rohit Verma, Nand Kumar
Abstract Objectives Alcohol use disorder (AUD) is a chronic disorder with various health problems. Reduced functioning of the Dorsolateral Prefrontal Cortex (DLPFC) is associated with impaired regulation of alcohol-seeking behaviors and increased cravings in individuals with AUD. This study aimed to investigate whether 10 add-on sessions of tDCS, over the left DLPFC in detoxified inpatients with AUD
-
Prevalence and services for the treatment of chronic pain at residential substance treatment centers Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-09-04 Christine Ramdin, Amanda Azer, Naila Ghafoor, Kyrillos Attaalla, Mina Ghbrial, Lewis Nelson
Abstract Introduction: Studies suggest that a large proportion of patients with substance use disorders (SUDs) also have underlying chronic pain. There is limited data on prevalence of chronic pain treatment as a component of residential substance use treatment. This initiative sought to investigate the prevalence and type of chronic pain services offered at these residential programs.Methods: This
-
Survey of barriers and opportunities for prescribing buprenorphine for opioid use disorder in Alabama. Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-08-31 Ishika Patel,Li Li,Haelim Jeong,Justin T McDaniel,Shanna McIntosh,Ellen Robertson,David L Albright
Opioid-related overdose deaths have significantly increased in the USA and in Alabama. Despite this, medications for opioid use disorder (MOUD) remains significantly underutilized. Thus, this study aims to gain a better understanding of clinicians' viewpoints on potential barriers and opportunities that are likely to impact and improve the access to MOUD, especially buprenorphine prescribing. A cross-sectional
-
Causal inference in tobacco research: a public health challenge. Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-08-31 Mohammad Ebrahimi Kalan,Kenneth D Ward,Paul T Harrell,Ziyad Ben Taleb
Causal inference represents a rapidly expanding interdisciplinary subfield that involves various assumptions, study designs, and estimation strategies, allowing researchers to establish causal relationships from both clinical trials and observational data. In tobacco research, numerous studies address causal questions, including the contentious issue of whether vaping in nonsmoking youth leads to smoking
-
Peer bullying victimization in adolescence is associated with substance use: cross-sectional findings from French high school students. Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-08-26 Guillaume Airagnes,Camille Perrotte,Géraldine Ducoutumany,Cédric Lemogne,Frédéric Limosin
The relationships between peer bullying victimization in adolescence and substance use have been poorly studied. Thus, we examined the associations between peer bullying victimization and tobacco, alcohol and cannabis use in 496 French high school students. Peer bullying victimization was measured with a 17-item standardized assessment and analyzed as quartiles. Tobacco, alcohol, and cannabis use were
-
Sex differences in variables affecting short-term success in substance use disorder treatment. Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-08-25 Kishan Desai,Vivian Hagerty,Varun Hariharan,Monica Perdomo,Elie Levy,Deepak Berwal,Ximena Levy,Julie Pilitsis
Because of the stigma surrounding patients with substance use disorder (SUD) and difficulties with follow-up, data on outcomes is limited. We explore real-world data from a prospectively collected database to determine characteristics that contribute to the completion of acute treatment. Our cohort consisted of data from 1039 patients treated at a single facility. Success was defined as successful
-
Operationalizing person-centered care in residential substance use disorder treatment Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-08-21 Barbara Andraka-Christou, Olivia K. Golan, Rachel Totaram, Morgan C. Shields, Kendall Cortelyou, Danielle N. Atkins, Glenn W. Lambie, Olena Mazurenko
Abstract Introduction Person-centered care (PCC) is an ethical imperative with eight domains, but operation of some PCC domains in substance use disorder (SUD) treatment has been underexplored. Objective We sought to identify strategies for operationalizing eight PCC domains in SUD treatment facilities and themes across these strategies. Methods We recruited 36 clients and staff from a large publicly
-
Correction Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-08-18
Published in Journal of Addictive Diseases (Ahead of Print, 2023)
-
Distress tolerance and problematic cannabis use: does the form of cannabis matter? Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-08-11 Melissa S. Najera, Jessica M. Cavalli, Anita Cservenka
Abstract Background Low distress tolerance may result in greater vulnerability to problematic cannabis use. However, the role of the primary form of cannabis used has not been examined as a moderator of this association. While marijuana flower remains the preferred form of cannabis, the popularity of other forms of cannabis, including concentrates and edibles, is on the rise. Objectives We examined
-
Comparison between cytisine and Nicotine Replacement Therapy in smoking cessation among inpatient psychiatric patients Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-08-11 Maria Tavakoli-Ardakani, Zeinab Gholamzadeh Sani, Narges Beyraghi, Shadi Najarimoghadam, Ali Kheradmand
Abstract Introduction: Smoking is more common among people with mental disorders and is associated with adverse effects. Some compounds, including nicotine and cytisine, have been used in many individuals to increase success in smoking cessation. In this study, the effect of cytisine on the smoking status of patients hospitalized in the psychiatry department was investigated. Method: Forty-seven patients
-
Prevalence of psilocybin use in vaping and associated factors: a study among amphetamine-type stimulants (ATS) use disorder in Malaysia Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-08-04 Ruzmayuddin Mamat, Rusdi Abd Rashid, Sim Maw Shin, Baharuddin Ibrahim, Suzaily Wahab, Azmir Ahmad
Abstract Background The emergence of New Psychoactive Substances (NPS), including synthetic psilocybin, has raised concern among health experts due to the numerous health and socioeconomic consequences. The current trend is shifting to the hazardous use of synthetic psilocybin in vaping, and little is known about the prevalence of use, specifically among amphetamine-type stimulants (ATS) users. Methods
-
Substance use disorders after natural disasters: a narrative review Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-07-30 Gamze Zengin İspir, Mustafa Danışman, Kübra Sezer Katar
Abstract Natural disasters significantly impact individuals and communities, including damage to infrastructure, injuries, loss of life, and psychological distress. Factors contributing to the development of substance use disorders (SUDs) during and after these events include trauma and stress, disruption of social support networks, availability of substances, and lack of access to mental health services
-
Cognitive, imaging, and psychiatric changes associated with chronic toluene use: case report and literature review Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-07-28 Madison Jupina, Jeremy Weleff, Jared Harp, Akhil Anand
Abstract Inhalant misuse and inhalant use disorder are global public health concern that impacts adolescents but can occur throughout life. Toluene is the most commonly misused inhalant. Toluene use leads to significant neuroanatomic, cognitive, and psychiatric deficits. The purpose of this study was to review and summarize the effects of toluene and present a case of a middle-aged patient with an
-
Central sensitization in alcohol use disorder: correlates of pain, addiction and health-related quality of life Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-07-22 O. Trent Hall, Parker Entrup, Anthony King, Michael Vilensky, Craig J. Bryan, Julie Teater, Julie Niedermier, Chelsea M. Kaplan, Jessica A. Turner, Stephanie Gorka, Steven E. Harte, David A. Williams, Daniel J. Clauw
Abstract Background Central sensitization is an important mechanism underlying many chronic pain conditions. Chronic pain and alcohol use disorder (AUD) are highly comorbid. Despite great scientific interest in brain mechanisms linking chronic pain and AUD, progress has been impeded by difficulty assessing central sensitization in AUD. Objective The present study is the first to employ a validated
-
The effect of sustainable low-dose sildenafil and cognitive-behavioral training on sexual function in methadone-treated men–a randomized controlled trial Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-07-18 Negah Tavakolifard, Zahra Amini
Abstract Background Sexual dysfunction caused by opioids is one of the serious problems of drug misusers. Objective This study aimed to evaluate and compare the effect of continuous low-dose sildenafil treatment alongside psychological training on the sexual function of methadone-treated patients. Method This randomized clinical trial was conducted on methadone-treated men with sexual dysfunction.
-
President’s message Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-07-19 Jon Lepley
Published in Journal of Addictive Diseases (Vol. 41, No. 4, 2023)
-
Pharmacotherapy and gambling disorder: a narrative review Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-07-09 Rezkalla Farkouh, Sophie Audette-Chapdelaine, Magaly Brodeur
Abstract Background Gambling disorder (GD) is a psychiatric disorder classified in the DSM-5 as a non-substance-related and addictive disorder with extensive health and socioeconomic impacts. Its chronic and high-relapsing nature makes it essential to find treatment strategies that improve functioning and reduce impairment associated with it. The purpose of this narrative review is to evaluate and
-
Genetic factors linked to aberrant neural activity of individuals with substance use disorder phenotypes: A systematic review and meta-analysis of EEG studies Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-07-09 Marco Cavicchioli, Andrea Galbiati, Valentina Tobia, Anna Ogliari
Abstract Background: Alterations in EEG activity have been considered valid endophenotypes of substance use disorders (SUDs). Empirical evidence has supported the association between genetic factors (e.g., genes, single nucleotide polymorphisms [SNPs]) and SUDs, considering both clinical samples and individuals with a positive family history of SUDs [F+SUD]). Nevertheless, the relationship between
-
Applying the theory of planned behavior to predict online addiction treatment intention Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-07-06 Hagit Bonny-Noach, Dudi Gold, Ariel Caduri
Abstract Scant research has been published on online addiction treatment, with few studies focusing on the Theory of Planned Behavior (TPB) in relation to addiction treatment. Therefore, this study aims to explain the TPB's predictability on intention and behaviors in relation to online addiction treatment among people recovering from substance use disorder (SUD). Methods This descriptive-analytical
-
Buprenorphine/naloxone micro-induction in a tertiary care hospital: a retrospective cohort analysis Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-07-02 Robert Nunn, Anne Sylvestre, Kelly Sequeira, Rosa Maria Tanzini
Abstract Objectives To describe the use of buprenorphine/naloxone micro-inductions in hospitalized patients and characterize the success rate of these inductions. Methods We conducted a retrospective chart review of hospitalized patients receiving a buprenorphine/naloxone micro-induction for opioid use disorder in a tertiary care hospital from Jan 2020–Dec 2020. The primary outcome was a description
-
Co-occurring pain and addiction: prognostic implications for healthcare professionals in residential treatment for substance use disorder Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-06-28 Apollonia E. Lysandrou, Scott A. Teitelbaum, Lisa Merlo, Ben Phalin, Amanda Janner, Laurie Solomon, Jason Hunt, Ben Lewis
Abstract Objectives: Chronic pain is both an important antecedent and consequence of substance use. Although evidence suggests healthcare professionals may be uniquely vulnerable to chronic pain, this vulnerability remains largely unexamined in the context of recovery from substance use disorders (SUDs). We characterized pain in a sample of treatment-seeking individuals, examined potential differences
-
Caring for patients with substance use disorders: a qualitative investigation of difficulties encountered by hospital-based clinicians Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-06-27 Sophie Paroz, Martine Monnat, Francesco Panese, Michael Saraga, Jean-Bernard Daeppen
Abstract Background: Caring for patients with substance use disorders (SUD) is held in low regard and many clinicians resist treating them. To address this situation, numerous research projects assessed training program gaps and professional attitudes. In contrast, this study explored the actual clinical difficulties that a variety of hospital-based professionals encounter when treating patients with
-
A systematic review on the impact of alcohol warning labels Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-05-22 Kayla M. Joyce, Myles Davidson, Eden Manly, Sherry H. Stewart, Mohammed Al-Hamdani
Abstract Findings on the effects of alcohol warning labels (AWLs) as a harm reduction tool have been mixed. This systematic review synthesized extant literature on the impact of AWLs on proxies of alcohol use. PsycINFO, Web of Science, PubMED, and MEDLINE databases and reference lists of eligible articles. Following PRISMA guidelines, 1,589 articles published prior to July 2020 were retrieved via database
-
Psychoactive plant derivatives (ayahuasca, ibogaine, kratom) and their application in opioid withdrawal and use disorder – a narrative review Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-05-18 Alexandra Arenson, Cynthia I. Campbell, Ilan Remler
Abstract The opioid epidemic and limited access to treatment for opioid withdrawal (OW) and opioid use disorder (OUD) has led individuals to seek alternative treatments. This narrative review aims to educate clinicians on the mechanisms of action, toxicity, and applications of psychoactive plant-based substances patients may be using to self-treat OUD and OW. We specifically discuss ayahuasca, ibogaine
-
Assessment of an observed clinical skills exam in undergraduate medical education: a patient with opioid use disorder and chronic pain Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-05-18 Halle G. Sobel, Amanda G. Kennedy, Leigh Ann Holterman, John Brooklyn, Angelika Hillios, Cate Nicholas, Elly Riser
Abstract It is crucial that future physicians understand the nature of opioid use disorder (OUD). We designed a pilot Observed Structured Clinical Examination (OSCE) using simulated patients (SPs) experiencing OUD with concurrent chronic pain. The case was piloted in 2021 and 2022 during the multi-station OSCE that all the medical school clerkship students take at the end of their third year of medical
-
President’s message Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-05-15 Jon Lepley
Published in Journal of Addictive Diseases (Vol. 41, No. 3, 2023)
-
Women over 50 who use alcohol and their engagement with primary and preventative health services: a narrative review using a systematic approach Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-05-10 Grainne Clarke, Pauline Hyland, Catherine Comiskey
Abstract Background Women who are over 50 years are drinking alcohol in higher quantities and more frequently than in previous decades. Good engagement with primary care is crucial for women’s physical and psychological health, particularly if they use alcohol. However, there is little known about the alcohol use of women over 50 and their use of primary care. Methods A systematic search was conducted
-
The integration of harm reduction services in the Veterans Health Administration (VHA): a qualitative analysis of barriers and facilitators Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-05-08 Leah H. Harvey, Samantha K. Sliwinski, Kimberlee Flike, Jacqueline Boudreau, Allen L. Gifford, Westyn Branch-Elliman, Justeen Hyde
Abstract Background Substance use is common among U.S. military veterans and veterans are at high risk for negative consequences associated with substance use, such as injection-related infections and overdose. Although harm reduction services (HRS) are highly evidence-based, implementation in traditional healthcare settings has been limited. This formative, qualitative study sought to identify barriers
-
Qualitative study on the perception of combustible cigarettes, e-cigarettes and heated tobacco cigarettes among pregnant women Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-03-09 Marilena Maglia, Maria C. Quattropani, Riccardo Polosa, Alessia Panassidi, Manuela Caruso, Marta Mangione, Valeria Nicolosi, Sonia D. Mazzeppi, Vittorio Lenzo, Alberto Sardella, Pasquale Caponnetto
Abstract The research proposes to investigate the psychological reasons that may explain women’s addiction to smoking during pregnancy and the perception of combustible cigarettes, electronic cigarettes and heated tobacco cigarettes. The sample included 30 participants who smoke or people who previously smoked who chose to quit or continue smoking during pregnancy. The data was gathered via a semi-structured
-
Years of life lost due to unintentional drug overdose relative to the leading underlying causes of death in the United States: a comparative analysis of excess mortality 2017–2019 Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-03-06 Stephanie Garcia, Julie Teater, Candice Trimble, Parker Entrup, Orman E. Hall, O. Trent Hall
Abstract The present study aims to compare Years of Life Lost for unintentional drug overdose and the leading underlying causes of death in the United States annually from 2017 to 2019. Years of Life Lost provide valuable context to incident deaths when comparing the relative mortality burden of underlying causes of death. Prior research has shown unintentional drug overdose was the third leading cause
-
Transcranial direct current stimulation combined with cognitive training improves decision making and executive functions in opioid use disorder: a triple-blind sham-controlled pilot study Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-03-02 Serkan Aksu, Ahmet Zihni Soyata, Sercan Şeker, Gözde Akkaya, Yasemin Yılmaz, Tuğba Kafalı, Cüneyt Evren, Gökhan Umut
Abstract Background: Opioid use disorder (OUD) is a chronic disorder with a considerable amount of morbidity and mortality. Despite remarkable improvement achieved by maintenance programs, an array of treatment goals were still unmet. Mounting evidence suggests that transcranial Direct Current Stimulation (tDCS) improves decision making and cognitive functions in addictive disorders. tDCS paired with
-
A scoping review of spirituality in relation to substance use disorders: Psychological, biological, and cultural issues Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-02-11 Marc Galanter, William L. White, Jag Khalsa, Helena Hansen
Abstract Background Spirituality is a construct encompassing a diversity of strongly held beliefs and pursuits related to life’s meaning and purpose. Empirical studies in key domains of spirituality related to substance use disorder (SUD) can be valuable in guiding research, and potentially clinical care. Objectives To conduct a scoping review of research on the psychological, biological, and cultural
-
Characterizing the use, preferences, and perceptions of flavors in cigars in pregnant women Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-02-03 Nancy C. Jao, George D. Papandonatos, Jocelyn Stanfield, Katelyn Borba, Laura R. Stroud
Abstract Background Flavors contribute to the appeal of tobacco products, but less is known about flavors in cigar products. The current study is the first to focus on characterizing the use and perceptions of flavors in cigar products among pregnant women. Methods Pregnant women (N = 124) reported their use, preferences (liking, attractiveness, smoothness, interest), perceptions of harm (general,
-
The experience of methamphetamine use disorder and the negative consequences of relapse – a qualitative study Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-01-19 Talia Klein, Daniel Terry, Blake Peck
Abstract Background The rate of relapse for people in recovery for substance use disorder is as high as 85% within the first 12 months of recovery, however, research on the lived experience of relapse is limited. Objective The present qualitative study investigated the experience of relapse with people who have Methamphetamine use disorder and the reasons why they returned to recovery. Methods The
-
Repeated measures analysis of opioid use disorder treatment on clinical opiate withdrawal scale in a randomized clinical trial: sex differences Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-01-19 Kesheng Wang, Saima Shafique, Danqing Xiao, Suzy Mascaro Walter, Ying Liu, Ubolrat Piamjariyakul, Changchun Xie
Sex differences may exist in opioid use disorder (OUD) treatment. This study examined the treatment effects of buprenorphine/naloxone (BUP/NX) and methadone (MET) on the Clinical Opiate Withdrawal ...
-
Geographic variation in availability of opioid treatment programs across U.S. communities Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-01-16 Sadia Jehan, Whitney E. Zahnd, Nikki R. Wooten, Kristen D. Seay
Abstract Methadone for Opioid Use Disorder (OUD) treatment is only dispensed at Opioid Treatment Programs (OTPs). Little is known about the geographic variation in OTP availability and community characteristics associated with the availability across smaller geographic communities in the U.S. To (1) describe geographic distribution of OTPs and (2) examine OTP availability by community characteristics
-
Commentary: Cigarette dependence in menthol and non-menthol young adult cigarette smokers Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-01-06 Kimberly Frost-Pineda, Michael Polster
Abstract FDA’s Proposed Final Rule to ban menthol cigarettes asserts that “menthol cigarettes contribute to greater nicotine dependence in youth and young adults than non-menthol cigarettes.” However, none of the publications referenced included young adults. To provide empirical evidence on the subject, we examine smoking frequency and Heaviness of Smoking Index (HSI) dependence among 2,194 young
-
Erectile Dysfunction in Alcohol Use Disorder and the change in erectile function after one month of abstinence Journal of Addictive Diseases (IF 2.065) Pub Date : 2023-01-06 Aravind Karunakaran, Anil Prabhakaran, Vidhukumar Karunakaran, Jaimon Plathottathil Michael
Abstract Objective The association between alcohol use and erectile dysfunction (ED) has not been explored adequately. The aim of this study is (i) to determine the prevalence of ED in patients with Alcohol use disorder (AUD), (ii) the association of ED with sociodemographic and clinical variables, (iii) the association between severity of drinking and sociodemographic and clinical variables, and (iv)